Vaccinex, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
Vaccinex, Inc. (VCNX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 24 shares for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2025-04-15
- Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2024-12-31 was 0.00 shares.
- Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2024-09-30 was 0.00 shares.
- Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2024-06-30 was 12.00 shares, a 99.80% decline year-over-year.
- Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2024-03-31 was 12.00 shares, a 99.98% decline year-over-year.
- Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 24.00 shares, a 92.23% decline from fiscal 2023.
- Vaccinex, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2023 was 309.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | 0.00 shares derived: sum of 2 quarters · filed 2025-04-15 | 12.00 shares derived: sum of 3 quarters · filed 2025-04-15 | 24.00 shares 10-K · filed 2025-04-15 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 12.00 shares derived: sum of 2 quarters · filed 2024-11-14 | 24.00 shares 10-Q · filed 2024-11-14 | -4.05K shares derived: sum of 4 quarters · filed 2025-04-15 |
| 2024-06-30 | 12.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 24.00 shares 10-Q · filed 2024-08-14 | -4.05K shares derived: sum of 3 quarters · filed 2025-04-15 | -65.49K shares derived: sum of 4 quarters · filed 2025-04-15 |
| 2024-03-31 | 12.00 shares 10-Q · filed 2024-05-15 | -4.07K shares derived: sum of 2 quarters · filed 2025-04-15 | -65.50K shares derived: sum of 3 quarters · filed 2025-04-15 | -59.50K shares derived: sum of 4 quarters · filed 2025-04-15 |
| 2023-12-31 | -4.08K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -65.51K shares derived: sum of 2 quarters · filed 2025-04-15 | -59.51K shares derived: sum of 3 quarters · filed 2025-04-15 | 309.00 shares 10-K · filed 2025-04-15 |
| 2023-09-30 | -61.43K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -55.43K shares derived: sum of 2 quarters · filed 2023-11-13 | 4.39K shares 10-Q · filed 2023-11-13 | |
| 2023-06-30 | 6.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 65.82K shares 10-Q · filed 2023-08-14 | ||
| 2023-03-31 | 59.82K shares 10-Q · filed 2023-05-15 |